Sociedad Americana de Hirudoterapia

Identification and characterization of a new member of snake venom thrombin inhibitors from Bothrops insularis using a proteomic approach

Research article published in Toxicon (2007)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Desarrollo de fármacosOliveira-Carvalho AL et al. · Toxicon, 2007

Abstract

Snake venom C-type lectin-like proteins (CLPs) are ubiquitously found in Viperidae snake venoms and differ from the C-type lectins as they display different biological activities but no carbohydrate-binding activity. Previous analysis of the transcriptome obtained from the Bothrops insularis venom gland showed the presence of two clusters homologous to bothrojaracin (BJC) chains alpha and beta. In an effort to identify a new BJC-like molecule, we used an approach associated with proteomic technologies to identify the presence of the expressed protein and then to purify and characterize a new thrombin inhibitor from B. insularis venom. We also constructed homology models of this protein and BJC, which were compared with other C-type lectin-like family members and revealed several conserved features of this intriguing snake venom toxin family.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsAmino Acid SequenceAnimalsAnticoagulantsBothropsCrotalid VenomsModels, MolecularMolecular Sequence DataProteomicsThrombin

Resumen

Identification and characterization of a new member of snake venom thrombin inhibitors from Bothrops insularis using a proteomic approach.

Por qué esto importa para la hirudoterapia

This study used a proteomic approach to identify and characterize a new thrombin inhibitor from Bothrops insularis snake venom, identified as a C-type lectin-like protein homologous to bothrojaracin. Researchers successfully purified the expressed protein and constructed molecular homology models to compare its structural features with other intriguing snake venom toxins. Although the research centers on isolating a thrombin inhibitor—a functional class that conceptually parallels the leech secretome's anticoagulant properties like hirudin—the molecule is entirely derived from snake venom. As a result, the study presents no leech-related data and possesses no direct relevance to clinical hirudotherapy.

Citación

Identification and characterization of a new member of snake venom thrombin inhibitors from Bothrops insularis using a proteomic approach

Oliveira-Carvalho AL et al. · Toxicon, 2007

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.